Researchers in Brazil discover a gene that may afford protection against COVID-19
Peer-Reviewed Publication
Updates every hour. Last Updated: 18-Jun-2025 18:10 ET (18-Jun-2025 22:10 GMT/UTC)
Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of the small and large intestines — bypassing the liver upon systemic administration. By simply altering the composition of the nanoparticles, the researchers demonstrated that mRNA-based drugs can be directed straight to target cells, avoiding the liver.
In a study on public psychology with regard to the COVID-19 pandemic, researchers from Osaka University found no significant differences among regions of Japan regarding either risk perception or infection-prevention behaviors during the “state of emergency,” suggesting spillover effects between targeted and non-targeted regions. However, risk perception diminished after restrictions were lifted, and both risk perception and hygienic behaviors saw further reductions after the downgrading of the legal status of COVID-19 to that of a common seasonal flu.
Kyushu University economists have published new data on the economic, social, and environmental impact of the COVID-19 pandemic on Japan's inbound tourism industry for the year 2020. The results showed a pandemic-induced loss of 33 million tourists, resulting in 3.44 trillion yen of value-added loses, and a decline in employment for 868,976 people. The data also revealed environmental benefits, with an emission reduction of 11.6 megatons of CO2.
Firearm injuries that sent victims to the hospital had gone down steadily over the five years before the COVID-19 pandemic began, but reversed course sharply over the next two years, a new University of Michigan study finds.
A study by the Università Cattolica, Rome campus - Fondazione Policlinico Universitario A. Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS, published in the Nature Group journal ‘Pediatric Research’, identifies the ‘protein signature’ of the condition in plasma, a group of pro-inflammatory molecules present at high concentrations in young patients with the condition. An Artificial Intelligence (AI) tool makes the diagnosis based on the results of the blood sample.